HCP Live February 20, 2024
Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.
New research is providing further evidence of the utility of time in range and other advanced continuous glucose monitoring (CGM) metrics in the prevention of negative microvascular outcomes in people with type 1 diabetes.
A retrospective analysis of CGM data from more than 160 adult patients, results of the study suggest time in range, time in tighter range, time above range, and mean glucose were associated with increased risk for incident diabetic retinopathy in adults with type 1 diabetes, which underline the importance of glycemic...